淫羊藿提取物

品名: 淫羊藿提取物
CAS號.: 489-32-7
分子式: C33H40O15 
有效成分: 淫羊藿單甙, 淫羊藿雙甙
規格: Icariin 5%-98%   
提取部位 : Leaf 
顏色: 棕色粉末
目數:80 Mesh
檢測方式: HPLC

【產品名稱】 淫羊藿甙

【產品別名】 淫羊藿甙,淫羊藿提取物,淫養藿提取物,淫羊霍苷

【英文名稱】Epimedium breviconum P.E.

【產品簡介】本品選擇秦巴山脈野生小檗科植物心葉淫羊藿Herba Epimedii的乾燥地上部。

【有效成分】 淫羊藿單甙icariin、淫羊藿雙甙icariins、淫羊藿黃酮Barrenwort flavonoids

【分子式】C33H40O15

【分子量】676.66

【產品規格】5% 、10%、20% 、98%

【檢測方法】HPLC/TLC

【產品性狀】 棕色粉末

【產品熔點】 熔點231℃-232℃

【溶解度】25℃下淫羊藿苷在水中的平衡溶解度為15.04mg/L

【包 裝】 1kg鋁箔袋/25kg紙板桶

【保 存】密封置於陰涼乾燥處

【保質期】24個月

 

產品詳詢:13657416805

參考文獻:

 

  1. 1. 

    Davison S, Davis SR (2003) Hormone replacement therapy: current controversies. Clin Endocrin 58:249–261

  2. 2. 

    Sakamoto S, Sassa S, Kudo H et al (2000) Preventive effects of a herbal medicine on bone loss in rats treated with a GnRH agonist. Euro J Endocrinol 143:139–142 

  3. 3. 

    Yamaguchi M, Hashizume M (1994) Effect of beta-alanyl-L-histidinato zinc on protein components in osteoblastic MC3T3-El cells: increase in osteocalcin, insulin-like growth factor-I and transforming growth factor-beta. Mol Cell Biochem 136:163–169

  4. 4. 

    Relea P, Revilla M, Ripoll E et al (1995) Zinc, biochemical markers of nutrition, and type I osteoporosis. Age Aging 24:303–307

  5. 5. 

    Saltman PD, Strause LG (1993) The role of trace minerals in osteoporosis. J Am Coll Nutr 12:384–389

  6. 6. 

    Seo JH, Jin YH, Jeong HM et al (2009) Calmodulin-dependent kinase II regulates Dlx5 during osteoblast differentiation. Biochem Biophys Res Commun 384:100–104

  7. 7. 

    Reid IR, Ames RW, Evans MC et al (1993) Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 328:460–464

  8. 8. 

    Keen CL, Zidenberg-Cherr S (1996) Manganese. In: Ziegler EE, Filer LJ (ed) Present knowledge in nutrition, 7th edn. ILSI Press, Washington D.C, pp 334–343 

  9. 9. 

    Hidaka S, Okamoto Y, Nakajima K et al (1997) Preventive effects of traditional chinese (Kampo) medicines on experimental osteoporosis induced by ovariectomy in rats. Calcif Tissue Int 61:239–246

  10. 10. 

    Xie F, Wu CF, Lai WP et al (2005) The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro. Evid Based Complement Alternat Med 2:353–361

  11. 11. 

    Chen KM, Ge BF, Ma HP et al (2004) The serum of rats administered flavonoid extract from Epimedium sagittatum but not the extract itself enhances the development of rat calvarial osteoblast-like cells in vitro. Pharmazie 59:61–64

  12. 12. 

    Chen HL, Liu XY (1989) A probe into the relationship between virtue of Chinese medicine and four trace elements. Chin J Chin Mater Med 14:36–39

  13. 13. 

    Zhao J, Jin RG, Luo L (2007) A correlation between the anti-HIV properties of Chinese medicinal herbs and their trace element content. J Beijing Univ Chem Technol 34:467–471 

  14. 14. 

    Cheng Y, Wang NL, Wang XL et al (2006) Chemical constituents from Epimedium koreanum Nakai. Journal of Shenyang Pharmaceutical University 23:644–647 

  15. 15. 

    Li XH, Zhang JC, Sui SF et al (2005) Effect of daidzin, genistin and glycitin on the osteogenic and adipogenic differentiation of bone marrow stromal cells and the adipocytic trans-differentiation of osteoblasts. Acta Pharmacol Sin 26:1081–1086 

  16. 16. 

    Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65:55–63

  17. 17. 

    Gray TK, Flynn TC, Gray KM et al (1987) 17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106. Proc Natl Acad Sci USA 84:6267–6271

  18. 18. 

    Siggelkow H, Schulz H, Kaesler S et al (1999) 1, 25 Dihydroxyvitamin-D3 attenuates the confluence-dependent differences in the osteoblast characteristic protei